CDC and ATSDR Health Message Testing System

ICR 201502-0920-001

OMB: 0920-0572

Federal Form Document

Forms and Documents
Document
Name
Status
Form and Instruction
New
Form
New
Form and Instruction
New
Form
New
Form
New
Form
New
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Form
New
Form
New
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Form
New
Form
New
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Supporting Statement A
2015-02-09
Supplementary Document
2015-02-05
Supplementary Document
2015-02-05
Supplementary Document
2015-02-05
Supplementary Document
2015-02-05
Supplementary Document
2015-02-05
Supplementary Document
2015-02-05
Supplementary Document
2015-02-05
Supplementary Document
2015-02-05
Supplementary Document
2015-02-05
Supplementary Document
2015-02-05
Supporting Statement B
2015-02-05
Supplementary Document
2011-11-09
IC Document Collections
IC ID
Document
Title
Status
230309 New
230289 New
230191 New
229935 New
229832 New
229773 New
229714 New
228955 New
228558 New
228002 New
227732 New
227267 New
227266 New
227066 New
227054 New
227053 New
227003 New
226565 New
226499 New
226496 New
226286 New
226047 New
225789 New
225268 New
224378 New
222786 New
222248 New
221858 New
221856 New
221594 New
221338 New
221272 New
221070 New
220252 New
ICR Details
0920-0572 201502-0920-001
Historical Active 201501-0920-003
HHS/CDC
CDC and ATSDR Health Message Testing System
Extension without change of a currently approved collection   No
Regular
Approved without change 03/30/2015
Retrieve Notice of Action (NOA) 02/11/2015
Approved consistent with the following terms of clearance: For each information collection, a GenIC information collection request will be prepared and submitted to OMB for review and approval. Any changes to the ICR will also be submitted to OMB for review and approval.
  Inventory as of this Action Requested Previously Approved
03/31/2018 36 Months From Approved 03/31/2015
55,575 0 55,575
7,410 0 7,510
0 0 0

CDC must communicate about hazards, outbreaks and other emergencies that present an urgent health threat to the public. Untested messages can waste communication resources and opportunities because the messages can be perceived as unclear or irrelevant. OADC-CDC requests an extension for the generic clearance for an expedited review of items to be used in health message testing to ensure the public will understand health messages and take recommended action.

US Code: 42 USC 241 Name of Law: Public Health Service Act
  
None

Not associated with rulemaking

  79 FR 69478 11/21/2014
80 FR 7477 02/10/2015
No

34
IC Title Form No. Form Name
HMTS - Formative evaluation of Zika prevention strategies and messages among pregnant women and community leaders in Puerto Rico NA, NA, NA, NA, NA, NA Focus Group Discussion with Community Leaders in Puerto Rico to Explore Possible Actions for Preventing Zika ,   Focus Group Discussion with Pregnant Women in Puerto Rico to Explore Possible Actions for Preventing Zika ,   Focus Group Discussion with Pregnant Women in Puerto Rico To Test Zika Prevention Messages ,   In-depth Interview of Community Leaders in Puerto Rico to Explore Possible Actions for Preventing Zika ,   In-depth Interview of Pregnant Women in Puerto Rico to Explore Possible Actions for Preventing Zika ,   In-depth Interview of Pregnant Women in Puerto Rico To Test Zika Prevention Messages
High Impact Prevention Message Testing (HIPMT) NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA Consumer Focus Group Guide ,   Consumer IDI Guide ,   Provider Focus Group Guide ,   Provider IDI Guide ,   Professional Focus Group Guide ,   Professional IDI Guide ,   Consumer - Brief Survey ,   Provider - Brief Survey ,   Professional - Brief Survey ,   Consumer - Screener ,   Provider - Screener ,   Professional - Screener ,   Consumer - Consent ,   Provider - Consent ,   Professional - Consent ,   Consumer Web Survey ,   Intercept Guide ,   Screener - Consumer Web Survey ,   Consent - Consumer Web Survey ,   Consent - Intercept Survey
Asthma Control Initiative Communication Messaging and Materials Development none Focus Group Screener
GenIC Testing of Spanish-language Messages for the National Diabetes
Domestic Readiness Initiative on Zika Virus Disease 0920-0572, 0920-0572, 0920-0572, 0920-0572, 0920-0572, 0920-0572 Attachment 4 - Provider Screener_1_13 ,   Attachment 5 - Provider Survey_1_13 ,   Attatchment 6 - FGPRScreener_1_13 ,   Attachment 7 - FGPRGuide_1-13-17 ,   ttachment2 - Consumer Screener for IDICONUS_1_13 ,   Attachment 3 consumer IDI Guide_l1_13
Interim Assessment of Messages for the Prescription Drug Overdose Prevention, Awareness, and Knowledge Building Campaign N/A Screen Shots of the Prescription Drug Overdose Survey
Bring Your Brave Campaign Message Testing none Bring Your Brave Campaign Testing Survey
HEADS UP Audience Research Study NA, NA FOCUS GROUP SCREENER AND FOLLOW UP FOCUS GROUP SCREENER ,   FOCUS GROUP AND FOLLOW UP FOCUS GROUP INSTRUMENT
Air Quality Information Initiative none Recruitment screener
Domestic Readiness Initiative on Zika Virus Disease - Year 2 Core Campaign Materials NA, NA Focus Group Screener ,   Focus Group Guide
Focus Group Research to Inform the Development of Mesages to change Social Norms Att. F2, Att. F1 Att. F1 Dads book ,   Att. F2 Moms book
Message testing among partners of pregnant women in Puerto Rico NA, NA Intercept Interviews with Public Audiences in Puerto Rico to test Zika Prevention Messages - English ,   Intercept Interviews with Public Audiences in Puerto Rico to test Zika Prevention Messages - Spanish
Re-entry Messaging Following a Radiation Emergency
Older Adult Mobility Planning Brochure none Participant Screener
Domestic Readiness Initiative on Zika Virus Disease: Year 2 Message & Materials Testing NA, NA, NA, NA Community Leader - Focus Group Screening Instrument ,   Men/Women Reproductive Age (18-49) - Focus Group Screening Instrument ,   Community Leader - Focus Group Guide ,   Men/Women Reproductive Age (18-49) - Focus Group Guide
CDC/NCEH TO21: Outdoor Air Quality Focus Group
"Bring Your Brave" Campaign Messages for Young Women and Health Care Providers 0920-0572, 0920-0572, 0920-0572, 0920-0572 Screening Instrument for Young Women ,   Survey Instrument for Young Women ,   Screening Instrument for Health Care Providers ,   Survey Instrument for Health Care Providers
Sepsis Educational Awareness Message/Materials Assessment - HCP none Sepsis Educational Awareness Assessment
Sepsis Campaign Development: Round 2 Concept/Materials Testing for Healthcare Providers n/a Screenshots of the Sepsis Survey for Healthcare Professionals
HMTS - Message testing among important public audiences in Puerto Rico NA Intercept Interviews with Public Audiences in Puerto Rico to test Zika Prevention Messages
Intercept Interviews with Travelers in Puerto Rico To Test Zika Prevention Messages NA, NA Intercept Interviews with Public Audiences in Puerto Rico To Test Zika Prevention Messages - English ,   Intercept Interviews with Public Audiences in Puerto Rico To Test Zika Prevention Messages - Spanish
Sepsis Educational Awareness Message/Materials Assessment - Consumers none Sepsis Assessment - Consumers
Radiation Concepts/Comparison Message Testing none, none Interview Screener ,   Focus Group Screener
Office of the Associate Director for Communication (OADC) Message and Material Feedback NA, NA OADC Message and Material Feedback Survey - Screener ,   OADC Message and Material Feedback Survey - Health Material Questions
Message Testing with Mothers for CDC's Division of Nutrition, Physical Activity, and Obesity (DNPAO) n/a, n/a Screener and Survey for Online Participants (content is provided in screen shots and Word) ,   Screener and Moderator's Guide for In-person Focus Group Participants
Assess Perception and Use of CDC Guideline for Prescribing Opioids for Chronic Pain none CDC Prescription Opioid Physician Survey
Skin Cancer Messages among Racial Ethnic Groups at Risk for Delayed Diagnosis, Advanced Disease and Lower Survival N/A, N/A, N/A, N/A, N/A, N/A, N/A Screener ,   Informed Consent and Rescreening Form ,   Focus Group Discussion Guide for African American Women ,   Focus Group Discussion Guide for Hispanic Women ,   Focus Group Discussion Guide for African American Men ,   Focus Group Discussion Guide for Hispanic Men ,   Digital Ad Response Sheet (completed during focus groups with men)
Antibiotic Use Campaign: Round 2 (R2) Concept/Materials Testing with Consumers n/a, n/a, n/a, n/a, n/a Pre-discussion Information Survey for Consumers (Self-demanders and Self-expectors) ,   Pre-discussion Information Survey for Consumers (Caregiver-demanders and Caregiver-expectors) ,   Online Focus Group Guide for Consumers ,   Screener for Consumers (Self-demanders and Self-expectors) ,   Screener for Consumers (Caregiver-demanders and Caregiver-expectors)
Antibiotic Use Campaign: Round 2 (R2) Concept/Materials Testing with Health Care Professionals n/a, n/a, n/a Screener for Health Care Professionals ,   Pre-Discussion Information Survey for Health Care Professionals ,   In-Depth Interview Guide for Health Care Professionals
Message Testing among Public Audiences in US Virgin Islands for Zika prevention none Intercept interview for message testing
Asthma Control Communication Materials Field Testing (NCEH) none, none, none, none, none Foduc Group Screener ,   Youth Rating Worksheet ,   Caregiver Rating Worksheet ,   Youth Comparison Worksheet ,   Caregiver Comparison Worksheet
Be Antibiotics Aware Educational Message/Materials Assessment n/a Be Antibiotics Aware Consumer Survey (BAACS)
Sepsis Campaign Development: Round 2 Concept/Materials Testing for Consumers n/a Screenshots of the Sepsis R2 Survey for Consumers
American Academy of Pediatrics Oral Health Toolkit Research and Message Testing

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 55,575 55,575 0 0 0 0
Annual Time Burden (Hours) 7,410 7,510 0 -100 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
Yes
Miscellaneous Actions
Burden change reverts estimated numbers back to original ICR; additional hours were added previously due to an unusually burdensome genIC.

$1,550,000
Yes Part B of Supporting Statement
No
No
No
No
Uncollected
Shari Steinberg 404 639-4942 sxw2@cdc.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
02/11/2015


© 2024 OMB.report | Privacy Policy